Detalhe da pesquisa
1.
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Nature
; 618(7965): 590-597, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258672
2.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Nature
; 602(7898): 664-670, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016195
3.
Design of universal Ebola virus vaccine candidates via immunofocusing.
Proc Natl Acad Sci U S A
; 121(7): e2316960121, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319964
4.
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Nature
; 619(7970): E50, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407829
5.
Simplified Purification of Glycoprotein-Modified Ferritin Nanoparticles for Vaccine Development.
Biochemistry
; 62(2): 292-299, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960597
6.
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study.
Allergy
; 76(3): 853-865, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997812
7.
How a Potent Anti-neuraminidase Monoclonal Antibody Navigates Recent Immune-evasive Influenza Strains: A Structural Study by Single-particle CryoEM.
Microsc Microanal
; 29(29 Suppl 1): 927, 2023 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37613467
8.
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines.
ACS Nano
; 18(4): 3214-3233, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215338
9.
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot.
Biomater Sci
; 11(6): 2065-2079, 2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723072
10.
Design of universal Ebola virus vaccine candidates via immunofocusing.
bioRxiv
; 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904982
11.
Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies.
Front Immunol
; 13: 942897, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36091016
12.
Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot.
bioRxiv
; 2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665002
13.
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.
Science
; 375(6583): 864-868, 2022 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076256
14.
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
Science
; 377(6608): 890-894, 2022 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857529
15.
Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
Protein Sci
; 30(4): 716-727, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586288
16.
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory.
ACS Cent Sci
; 7(7): 1191-1204, 2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341771
17.
An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory.
bioRxiv
; 2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880472
18.
A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice.
ACS Cent Sci
; 7(1): 183-199, 2021 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527087
19.
Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2.
Adv Mater
; 33(51): e2104362, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34651342
20.
Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2.
bioRxiv
; 2021 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821276